O	0	12	Inflammation
O	13	16	and
O	17	29	psychosocial
O	30	37	factors
O	38	45	mediate
B-intervention	46	54	exercise
O	55	62	effects
O	63	65	on
B-condition	66	71	sleep
I-condition	72	79	quality
O	80	82	in
O	83	89	breast
O	90	96	cancer
O	97	106	survivors
O	106	107	:
O	108	113	pilot
O	114	124	randomized
O	125	135	controlled
O	136	141	trial
O	141	142	.

O	143	145	To
O	146	153	improve
O	154	165	mechanistic
O	166	179	understanding
O	179	180	,
O	181	185	this
O	186	191	pilot
O	192	202	randomized
O	203	213	controlled
O	214	219	trial
O	220	228	examined
O	229	238	mediators
O	239	241	of
O	242	244	an
O	245	253	exercise
O	254	266	intervention
O	267	274	effects
O	275	277	on
O	278	283	sleep
O	284	286	in
O	287	293	breast
O	294	300	cancer
O	301	310	survivors
O	311	312	(
O	312	315	BCS
O	315	316	)
O	316	317	.

B-total-participants	318	323	Forty
I-total-participants	323	324	-
I-total-participants	324	327	six
B-eligibility	328	342	postmenopausal
I-eligibility	343	346	BCS
I-eligibility	347	348	(
I-eligibility	348	349	≤
I-eligibility	349	354	Stage
I-eligibility	355	357	II
I-eligibility	357	358	,
I-eligibility	359	362	off
I-eligibility	363	370	primary
I-eligibility	371	380	treatment
I-eligibility	380	381	)
O	382	386	were
O	387	397	randomized
O	398	400	to
O	401	402	a
O	403	404	3
O	404	405	-
O	405	410	month
O	411	419	exercise
O	420	432	intervention
O	433	435	or
B-control	436	443	control
I-control	444	449	group
O	449	450	.

O	451	463	Intervention
O	464	472	included
O	473	476	160
O	477	480	min
O	480	481	/
O	481	485	week
O	486	488	of
O	489	497	moderate
O	498	507	intensity
O	508	515	aerobic
O	516	523	walking
O	523	524	,
O	525	530	twice
O	531	537	weekly
O	538	548	resistance
O	549	557	training
O	558	559	(
O	559	569	resistance
O	570	575	bands
O	575	576	)
O	576	577	,
O	578	581	and
O	582	585	six
O	586	596	discussion
O	597	603	groups
O	604	605	(
O	605	607	to
O	608	615	improve
O	616	625	adherence
O	625	626	)
O	626	627	.

O	628	635	Blinded
O	636	647	assessments
O	648	650	at
O	651	659	baseline
O	660	663	and
O	664	668	post
O	668	669	-
O	669	681	intervention
O	682	690	included
O	691	696	sleep
O	697	708	disturbance
O	709	710	(
O	710	714	PSQI
O	715	718	and
O	719	725	PROMIS
O	725	726	®
O	726	727	)
O	727	728	,
O	729	738	objective
O	739	744	sleep
O	745	752	quality
O	753	754	(
O	754	767	accelerometer
O	767	768	)
O	768	769	,
O	770	775	serum
O	776	785	cytokines
O	785	786	,
O	787	800	accelerometer
O	801	809	physical
O	810	818	activity
O	818	819	,
O	820	837	cardiorespiratory
O	838	845	fitness
O	845	846	,
O	847	851	body
O	852	863	composition
O	863	864	,
O	865	872	fatigue
O	872	873	,
O	874	877	and
O	878	890	psychosocial
O	891	898	factors
O	898	899	.

O	900	909	Mediation
O	910	913	was
O	914	920	tested
O	921	926	using
O	927	935	Freedman
O	935	936	-
O	936	945	Schatzkin
O	946	956	difference
O	956	957	-
O	957	959	in
O	959	960	-
O	960	972	coefficients
O	973	978	tests
O	978	979	.

O	980	984	When
O	985	993	compared
O	994	998	with
O	999	1006	control
O	1006	1007	,
O	1008	1011	the
O	1012	1024	intervention
O	1025	1030	group
O	1031	1043	demonstrated
O	1044	1045	a
O	1046	1057	significant
O	1058	1066	increase
O	1067	1069	in
B-outcome	1070	1074	PSQI
I-outcome	1075	1080	sleep
I-outcome	1081	1089	duration
O	1090	1091	(
O	1091	1092	i
O	1092	1093	.
O	1093	1094	e
O	1094	1095	.
O	1095	1096	,
O	1097	1102	fewer
O	1103	1108	hours
O	1109	1111	of
O	1112	1117	sleep
O	1117	1118	/
O	1118	1123	night
O	1123	1124	)
O	1125	1126	(
O	1126	1127	d
O	1128	1129	=
O	1130	1131	0
O	1131	1132	.
O	1132	1134	73
O	1134	1135	,
O	1136	1137	p
O	1138	1139	=
O	1140	1141	.
O	1141	1143	03
O	1143	1144	)
O	1144	1145	.

O	1146	1152	Medium
O	1153	1155	to
O	1156	1161	large
O	1162	1165	but
O	1166	1169	non
O	1169	1170	-
O	1170	1181	significant
O	1182	1194	standardized
O	1195	1201	effect
O	1202	1207	sizes
O	1208	1212	were
O	1213	1218	noted
O	1219	1222	for
B-outcome	1223	1227	PSQI
I-outcome	1228	1235	daytime
I-outcome	1236	1246	somnolence
O	1247	1248	(
O	1248	1249	d
O	1250	1251	=
O	1252	1253	-
O	1253	1254	0
O	1254	1255	.
O	1255	1257	63
O	1257	1258	,
O	1259	1260	p
O	1261	1262	=
O	1263	1264	.
O	1264	1266	05
O	1266	1267	)
O	1268	1271	and
B-outcome	1272	1285	accelerometer
I-outcome	1286	1293	latency
O	1294	1295	(
O	1295	1296	d
O	1297	1298	=
O	1299	1300	-
O	1300	1301	0
O	1301	1302	.
O	1302	1304	49
O	1304	1305	,
O	1306	1307	p
O	1308	1309	=
O	1310	1311	.
O	1311	1313	14
O	1313	1314	)
O	1314	1315	.

O	1316	1318	No
O	1319	1332	statistically
O	1333	1344	significant
O	1345	1354	mediators
O	1355	1359	were
O	1360	1368	detected
O	1369	1372	for
B-outcome	1373	1377	PSQI
I-outcome	1378	1383	sleep
I-outcome	1384	1392	duration
I-outcome	1393	1398	score
O	1399	1401	or
B-outcome	1402	1415	accelerometer
I-outcome	1416	1423	latency
O	1423	1424	.

B-outcome	1425	1432	Daytime
I-outcome	1433	1443	somnolence
O	1444	1447	was
O	1448	1456	mediated
O	1457	1459	by
O	1460	1465	tumor
O	1466	1474	necrosis
O	1475	1481	factor
O	1481	1482	-
O	1482	1487	alpha
O	1488	1489	(
O	1489	1497	mediated
O	1498	1500	23
O	1500	1501	%
O	1502	1504	of
O	1505	1517	intervention
O	1518	1524	effect
O	1524	1525	,
O	1526	1527	p
O	1528	1529	<
O	1530	1531	.
O	1531	1533	05
O	1533	1534	)
O	1534	1535	,
B-outcome	1536	1547	interleukin
O	1548	1549	(
O	1549	1551	IL
O	1551	1552	)
O	1552	1553	-
O	1553	1554	6
O	1554	1555	:
O	1555	1557	IL
O	1557	1558	-
O	1558	1560	10
O	1561	1562	(
O	1562	1564	16
O	1564	1565	%
O	1565	1566	,
O	1567	1568	p
O	1569	1570	<
O	1571	1572	.
O	1572	1574	01
O	1574	1575	)
O	1575	1576	,
O	1577	1579	IL
O	1579	1580	-
O	1580	1581	8
O	1581	1582	:
O	1582	1584	IL
O	1584	1585	-
O	1585	1587	10
O	1588	1589	(
O	1589	1591	26
O	1591	1592	%
O	1592	1593	,
O	1594	1595	p
O	1596	1597	<
O	1598	1599	.
O	1599	1601	01
O	1601	1602	)
O	1602	1603	,
O	1604	1607	and
B-outcome	1608	1615	fatigue
O	1616	1617	(
O	1617	1619	38
O	1619	1620	%
O	1620	1621	,
O	1622	1623	p
O	1624	1625	<
O	1626	1627	.
O	1627	1629	05
O	1629	1630	)
O	1630	1631	.

O	1632	1641	Mediating
O	1642	1644	or
O	1645	1654	enhancing
O	1655	1668	relationships
O	1669	1672	for
O	1673	1680	several
O	1681	1683	of
O	1684	1687	the
O	1688	1693	sleep
O	1694	1702	outcomes
O	1703	1707	were
O	1708	1713	noted
O	1714	1717	for
O	1718	1731	accelerometer
O	1732	1740	physical
O	1741	1749	activity
O	1749	1750	,
O	1751	1757	PROMIS
O	1757	1758	®
O	1759	1766	fatigue
O	1766	1767	,
O	1768	1776	exercise
O	1777	1783	social
O	1784	1791	support
O	1791	1792	,
O	1793	1796	and
O	1796	1797	/
O	1797	1799	or
O	1800	1808	physical
O	1809	1817	activity
O	1818	1827	enjoyment
O	1827	1828	.

O	1829	1841	Inflammation
O	1842	1845	and
O	1846	1858	psychosocial
O	1859	1866	factors
O	1867	1870	may
O	1871	1878	mediate
O	1879	1881	or
O	1882	1889	enhance
O	1890	1895	sleep
O	1896	1904	response
O	1905	1907	to
O	1908	1911	our
O	1912	1920	exercise
O	1921	1933	intervention
O	1933	1934	.

O	1935	1942	Further
O	1943	1948	study
O	1949	1951	is
O	1952	1961	warranted
O	1962	1964	to
O	1965	1972	confirm
O	1973	1976	our
O	1977	1984	results
O	1985	1988	and
O	1989	1998	translate
O	1999	2002	our
O	2003	2011	findings
O	2012	2016	into
O	2017	2021	more
O	2022	2031	effective
O	2032	2045	interventions
O	2046	2051	aimed
O	2052	2054	at
O	2055	2064	improving
O	2065	2070	sleep
O	2071	2078	quality
O	2079	2081	in
O	2082	2085	BCS
O	2085	2086	.
